Mahindra Manulife
Focused Fund


(An open ended equity scheme investing in maximum
30 stocks across market caps (i.e Multi Cap))



One Pager as on February 29, 2024

 
Selection of the next potential winners through the GCMV process#
 
High conviction focused portfolio with strong risk management processes
 
Potential to generate relatively better risk adjusted returns
 

# GCMV is an internal process framework to optimize stock selection based on growth, cashflow, management and valuation

  • A high conviction diversified portfolio of companies that could benefit from emerging opportunities in the domestic scenario.

  • A flexi cap, multi sector approach of selecting around 30 stocks with potential medium to long term growth runway.
  • Key Overweight sectors/Industries include Oil & Gas, Construction Materials and Chemicals sector vs the Scheme’s Benchmark

  • Key Underweight sectors /Industries include Consumer Durables, Capital Goods and Banks vs the Scheme’s Benchmark
Sector MMFF NSE 500 Index TRI
Financial Services 27.27% 28.20%
Oil Gas & Consumable Fuels 16.25% 9.58%
Information Technology 10.16% 10.54%
Fast Moving Consumer Goods 7.08% 7.29%
Automobile And Auto Components 5.41% 6.79%

Data as on February 29, 2024

Security % to Net Assets
ICICI Bank Limited 8.44%
Reliance Industries Limited 8.36%
State Bank of India 6.44%
Infosys Limited 5.41%
Grasim Industries Limited 4.80%
Kotak Mahindra Bank Limited 4.01%
Hindustan Unilever Limited 3.60%
Indus Towers Limited 3.50%
Sun Pharmaceutical Industries Limited 3.36%
Coal India Limited 3.33%
Total 51.25%
Fresh Additions Complete Exits
Security Security
GAIL (India) Limited Gujarat State Fertilizers & Chemicals
IndusInd Bank Limited Larsen & Toubro Limited
Union Bank of India NHPC Limited
- Piramal Enterprises Limited


Note: The companies/stock(s) referred above are only for the purpose of disclosure of significant portfolio changes during the month and should not be construed as recommendation to buy/sell/ hold. The fund manager may or may not choose to hold these companies/stocks, from time to time. Investors are requested to consult their financial, tax and other advisors before taking any investment decision(s). Data as on February 29, 2024

Turnover Ratio (Last 1 year) 0.80
Standard Deviation 12.77%
Beta 0.89
Sharpe Ratio# 1.30
Jenson's Alpha 0.4717


#Risk-free rate assumed to be 6.80% (MIBOR as on 29-02-24) - Source:www.mmda.org
Note: As per AMFI guidelines for factsheet, the ratios are calculated based on month rolling returns for last 3 years. Data as on February 29, 2024

Investment Objective:
The investment objective of the scheme is to generate long term capital appreciation by investing in a concentrated portfolio of equity & equity related instruments of maximum 30 companies across market capitalisation. However, there can be no assurance that the investment objective of the Scheme will be achieved.

Fund Manager:

Mr Krishna Sanghavi
Total Experience : 27 years
Experience in managing this fund: 3 years and 3 months (Managing since November 17, 2020)

Ms. Fatema Pacha
Total Experience : 18 years,
Experience in managing this fund: 3 years and 2 month (Managing since December 21, 2020)

Date of allotment: November 17, 2020

Benchmark: NSE 500 Index TRI

Option: IDCW (IDCW Option will have IDCW Reinvestment (D) & IDCW Payout facility) and Growth (D)
D-Default

Minimum Application Amount: Rs. 1,000 and in multiples of Re. 1/- thereafter

Minimum Weekly & Monthly SIP Amount: Rs 500 and in multiples of Re. 1/- thereafter

Minimum Weekly & Monthly SIP Installments: 6

Minimum Quarterly SIP Amount: Rs 1,500 and in multiples of Re. 1/- thereafter

Minimum Quarterly SIP installments: 4

Monthly AAUM as on February 29, 2024 (Rs. in Cr.): 1,156.75

Monthly AUM as on February 29, 2024 (Rs. In Cr.): 1,178.81

Entry Load: Not applicable

Exit Load: • An Exit Load of 1% is payable if Units are redeemed / switched-out upto 3 months from the date of allotment;
• Nil if Units are redeemed / switched-out after 3 months from the date of allotment.

^Benchmark ^^Additional Benchmark. Inception/Allotment date: 17-Nov-20.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Since inception returns of the scheme is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. *Based on standard investment of Rs. 10,000 made at the beginning of the relevant period. Ms. Fatema Pacha is managing this scheme since December 21, 2020

^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 17-Nov-20.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Returns greater than 1 year period are compounded annualized. For SIP returns, monthly investment of equal amounts invested on the 1st business day of every month has been considered. CAGR Returns (%) are computed after accounting for the cash flow by using the XIRR method (investment internal rate of return).

^Benchmark CAGR – Compounded Annual Growth Rate. Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Krishna Sanghavi manages 2 scheme and Ms. Fatema Pacha manages 8 schemes of Mahindra Manulife Mutual Fund. The performance data for the schemes which have not completed one year has not been provided.
Performance as on February 29, 2024

Scheme Name
Mahindra Manulife Focused Fund

This product is suitable for investors who are seeking*:
• Long term capital appreciation;
• Investment in equity and equity related instruments in concentrated portfolio of maximum 30 stocks across market capitalziation.

Scheme Riskometer

Scheme Benchmark
NSE 500 Index TRI

Benchmark Riskometer

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.

Readers of this material should rely on information / data arising out of their own investigations and advised to seek independent professional advice and arrive at an informed decision before making any investments. Neither Mahindra Manulife Investment Management Private Limited nor Mahindra Manulife Trustee Private Limited, its directors or associates shall be liable for any damages that may arise from the use of the information contained herein.

Get in Touch: Unit No. 204, 2nd Floor, Amiti Building, Piramal Agastya Corporate Park, LBS Road, Kamani Junction, Kurla (W), Mumbai – 400 070.
Phone: +91-22-66327900, Fax: +91-22-66327932
Toll Free No.: 1800 419 6244
Website: www.mahindramanulife.com

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.
CNo.01291